Labetalol Range

Labetalol PCD Pharma Franchise Company

Cafoli Lifecare is a trusted Labetalol PCD pharma franchise company offering 2 formulations in tablet and injection forms. Manufactured at WHO-GMP certified facilities, this range gives franchise partners a reliable antihypertensive valued especially in obstetric and emergency blood-pressure control.

What is Labetalol?

Labetalol is a combined alpha- and beta-adrenergic receptor blocker. By blocking beta-1, beta-2 and alpha-1 receptors it lowers blood pressure through reduced peripheral vascular resistance and heart rate, without a reflex tachycardia. Its balanced action and safety in pregnancy make it a preferred agent for several hypertensive states. Learn more on PubChem.

Therapeutic Applications of Labetalol

Labetalol is used to treat hypertension, including hypertension in pregnancy, pre-eclampsia and hypertensive emergencies where the intravenous form allows controlled blood-pressure reduction. It is prescribed by cardiologists, obstetricians, physicians and intensivists.

Why Labetalol is a High-Potential Molecule for Distributors

Labetalol occupies a defensible clinical niche as a first-line agent for pregnancy-induced hypertension and pre-eclampsia, conditions that require dependable in-hospital management, while its injectable form serves emergency and critical-care settings. This specialist, guideline-driven demand across obstetrics and emergency medicine gives distributors a steady, less price-sensitive antihypertensive molecule.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers exclusive district-wise monopoly rights, WHO-GMP certified and DCGI-approved formulations, attractive promotional inputs and marketing support, and the reliability of a network trusted by 1000+ franchise partners across India.

References

1. PubChem – Labetalol Compound Summary, U.S. National Library of Medicine
2. PubMed – Clinical literature on Labetalol